Table of Contents: Preface
Chapter 1. Bioequivalence: Some Relevant Clinical and Biopharmaceutic Aspects, pp. 1-45
(Francisco J. Flores-Murrieta, Miriam del C. Carrasco-Portugal, Héctor León-Molina and Miguel Luján, Sección de Estudios de Posgrado e Investigación, Escuela Superior de Medicina del Instituto Politécnico Nacional, México, D.F., México)
Chapter 2. Advances in Drug Discovery to Assess Cholinergic Neurotransmission, pp. 47-97
(David R. da Rocha, Vitor F. Ferreira, Kátia G. Lima Araújo, Wilson C. Santos, Departamento de Química Orgânica, Instituto de Química, Universidade Federal Fluminense, Niterói, RJ, Brazil, and others)
Chapter 3. Method Suitability for Models of Intestinal Drug Permeability, pp. 99-127
(Donna A. Volpe, Food and Drug Administration, Center for Drug Evaluation and Research, Silver Spring, MD)
Chapter 4. Stevens-Johnson Syndrome with Ocular Complication, pp. 129-150
(Mayumi Ueta, Department of Ophthalmology, Kyoto Prefectural University of Medicine, Kyoto, Japan, Research Center for Regenerative Medicine, Faculty of Life and Medical Sciences, Doshisha University, Kyoto, Japan)
Chapter 5. Prophylactic Effect of Rescalmin, an Antiallergic Agent, Against Hypersensitivity Reactions to Anticancer Drugs: Paclitaxel and Beyond, pp. 151-164
(Shinji Sasada, Department of Thoracic Malignancy, Osaka Prefectural Medical Center for Respiratory and Allergic Diseases, Osaka, Japan)
Chapter 6. Pharmacopoeial Quality of Antimicrobial and Antiviral Formulations from Former Soviet Union Republics: Focus on Aciclovir, pp. 165-176
(Andres Meos and Vallo Matto, Institute of Pharmacy, University of Tartu, Estonia)
Chapter 7. The Interaction of the Prion Protein with Triazine-based Biomimetic Affinity Ligands, pp. 177-190
(Giannis Mavridis and Nikolaos E. Labrou, Laboratory of Enzyme Technology, Department of Agricultural Biotechnology, Agricultural University of Athens, Athens, Greece)
Chapter 8. Downstream Processing Strategies for the Purification of Recombinant Proteins from Transgenic Maize. Chromatographic Evaluation of the Synthetic Affinity Ligand 4-Amino-phenyl-oxanilic acid, pp. 191-215
(Dimitris Platis and Nikolaos E. Labrou, Laboratory of Enzyme Technology, Department of Agricultural Biotechnology,
Agricultural University of Athens, Athens, Greece)
Chapter 9. A Critical Approach to an Allergic Paradox: Allergic and Allergic-Like Reactions to Glucocorticoids: Delayed Hypersensitivity Mechanisms, pp. 217-241
(M.T. Ventura, R. Buquicchio, G.F. Calogiuri, Department of Internal Medicine, Immunology and Infectious Diseases (MIDIM), University of Bari Medical School, Italy, and others)*
Index |